Table 2.
n | percentage | |
---|---|---|
T stage | ||
1 | 22 | 37.3% |
2 | 24 | 40.7% |
3 | 9 | 15.3% |
4 | 0 | 0.0% |
Not available | 4 | 6.8% |
Lymphe node metasases | ||
None | 24 | 40.7% |
Unilateral | 14 | 23.7% |
Bilateral | 6 | 10.2% |
Not available | 15 | 25.4% |
Distant metastases | ||
No | 28 | 47.5% |
Yes | 1 | 1.7% |
Not available | 30 | 50.8% |
FIGO | ||
I | 16 | 27.1% |
II | 12 | 20.3% |
III | 13 | 22.1% |
IV | 5 | 9.5% |
Not available | 13 | 22.0% |
Tumor differentiation | ||
Well | 13 | 22.0% |
Moderate | 30 | 50.8% |
Poor | 16 | 27.1% |